血液透析和持续性非卧床腹膜透析中的贫血与促红细胞生成素 - Suppr

Suppr

超能文献

Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.

作者信息

Korbet S M

机构信息

Rush Medical College, Chicago, Illinois.

出版信息

Kidney Int Suppl. 1993 Feb;40:S111-9.

PMID:8445832

Abstract

摘要

相似文献

Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.血液透析和持续性非卧床腹膜透析中的贫血与促红细胞生成素

Kidney Int Suppl. 1993 Feb;40:S111-9.

The adverse effects of recombinant human erythropoietin therapy.重组人促红细胞生成素治疗的不良反应。

Adverse Drug React Acute Poisoning Rev. 1990 Winter;9(4):183-206.

Indications and contraindications for recombinant human erythropoietin treatment. Results in hemodialysis patients.重组人促红细胞生成素治疗的适应证和禁忌证。血液透析患者的结果。

Contrib Nephrol. 1989;76:193-200; discussion 212-8.

Seizures in dialysis patients treated with recombinant erythropoietin.接受重组促红细胞生成素治疗的透析患者的癫痫发作

Nephrol Dial Transplant. 1995;10(3):423-4.

The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.重组人促红细胞生成素治疗终末期肾病透析患者贫血的临床疗效。

Southeast Asian J Trop Med Public Health. 1993 Sep;24(3):577-82.

[Erythropoietin treatment in children with chronic renal failure].

Nihon Rinsho. 1991 Dec;49 Suppl:688-94.

Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.

Semin Nephrol. 1989 Mar;9(1 Suppl 1):9-15.

[The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].[血液透析和持续性非卧床腹膜透析对肾性贫血的影响]

Srp Arh Celok Lek. 1997 May-Jun;125(5-6):163-7.

Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.接受重组人促红细胞生成素治疗的血液透析患者的血液流变学

Contrib Nephrol. 1989;76:306-12; discussion 312-4.

Erythropoietin use in peritoneal dialysis patients.促红细胞生成素在腹膜透析患者中的应用。

Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):38-41.

引用本文的文献

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.促红细胞生成素刺激剂反应性与血液透析和腹膜透析患者死亡率的关联

PLoS One. 2015 Nov 20;10(11):e0143348. doi: 10.1371/journal.pone.0143348. eCollection 2015.

Association between neutrophil geletinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis.中性粒细胞明胶酶相关脂质运载蛋白与慢性透析儿童缺铁性贫血之间的关联

J Res Med Sci. 2014 Jul;19(7):624-8.

Pharmacokinetics/pharmacodynamics of recombinant human erythropoietins in doping control.重组人促红细胞生成素在兴奋剂检测中的药代动力学/药效学

Sports Med. 2003;33(4):301-15. doi: 10.2165/00007256-200333040-00004.

Drugs for increasing oxygen and their potential use in doping: a review.提高氧气含量的药物及其在兴奋剂方面的潜在用途：综述

Sports Med. 2003;33(3):187-212. doi: 10.2165/00007256-200333030-00003.

Changes of endogenous erythropoietin level and iron status during a 30-month hemodialysis treatment of a group of patients.

Int Urol Nephrol. 2001;33(3):541-6. doi: 10.1023/a:1019558511411.

Clinical pharmacokinetics during continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析期间的临床药代动力学

Clin Pharmacokinet. 1996 Oct;31(4):293-308. doi: 10.2165/00003088-199631040-00005.

Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis.

Eur J Pediatr. 1994 Nov;153(11):850-4. doi: 10.1007/BF01972896.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验